ISRCTN ISRCTN08601529
DOI https://doi.org/10.1186/ISRCTN08601529
Secondary identifying numbers N/A
Submission date
07/09/2005
Registration date
14/12/2005
Last edited
20/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Prof Werner Herzog
Scientific

Im Neuenheimer Feld 410
Heidelberg
69120
Germany

Phone +49 (0)6221 56 8649
Email Wolfgang_Herzog@med.uni-heidelberg.de

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeQuality of life
Scientific title
Study acronymTTT
Study objectivesThe intervention will result in a change of the quality of life (Qol) (SF-36, scale physical function) of at least 7% compared to control.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCongestive Heart Failure (CHF)
InterventionFor the control group, a classic state of the art lecture of 1.5-3 hours on heart failure from a cardiologist is used. For the intervention group, an interactive training of 1.5 days plus a refresher course of 1.5-3 hours plus two quality circles (1.5 hours) is planned. Elements of the training apply to the domains of knowledge (guideline), communication (standardized patients), detection and management of psychiatric co-morbidity and organisation of the practice. An interactive format relating to andragogy is chosen. A tool box will be provided consisting of a variety of management algorithms and other helpful tools.
Intervention typeOther
Primary outcome measurePrimary outcome is health related quality of life (Qol) of patients with heart failure measured with SF-36, scale 1 (physical functioning). Change of Qol is measured from T1 to T2.
Secondary outcome measuresSecondary outcomes are the other dimensions: Qol of SF-36, the disease specific Qol (KCCQ), patient perceived quality of care (EUROPEP), readmission to hospital or death due to heart failure (combined), improvement of heart failure according to BNP.
Overall study start date12/10/2005
Completion date31/05/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants470 patients, 60 practices with 8 patients per practice
Key inclusion criteria1. Objective left- or bi-ventricular heart failure with an ejection fraction of 40% or less (affirmation of the limitation of the heart with echocardiography, no older then six months)
2. Age ≥40 years
3. Stability of the disease at the point of time of inclusion
Key exclusion criteria1. Primary valvular heart disease with relevant hemodynamic effects
2. Hypertrophic obstructive/restrictive cardiomyopathy (HOCM/RCM)
3. Organ transplantation
4. Acute left ventricular failure
5. Short life expectancy due to a serious concomitant illness
6. Impaired mental state that prevents accurate answers to questions
7. Addictive disorders with continuing drug abuse despite social, legal or professional conflicts
Date of first enrolment12/10/2005
Date of final enrolment31/05/2006

Locations

Countries of recruitment

  • Germany

Study participating centre

Im Neuenheimer Feld 410
Heidelberg
69120
Germany

Sponsor information

German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF])
Government

Hannoversche Straße 28-30
Berlin
10115
Germany

Phone +49 (0)1888 570
Email Gesundheitsforschung@dlr.de
ROR logo "ROR" https://ror.org/04pz7b180

Funders

Funder type

Government

German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 13/08/2009 Yes No